Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1966 Sep;45(9):1421–1432. doi: 10.1172/JCI105450

Experimental pneumococcal and staphylococcal sepsis: effects of hydrocortisone and phenoxybenzamine upon mortality rates.

H G Robson, L E Cluff
PMCID: PMC292822  PMID: 5919345

Full text

PDF
1421

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AUSTRIAN R., GOLD J. PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA. Ann Intern Med. 1964 May;60:759–776. doi: 10.7326/0003-4819-60-5-759. [DOI] [PubMed] [Google Scholar]
  2. BAEZ S., SRIKANTIA S. G., BURACK B. Dibenzyline protection against shock and preservation of hepatic ferritin systems. Am J Physiol. 1958 Jan;192(1):175–180. doi: 10.1152/ajplegacy.1957.192.1.175. [DOI] [PubMed] [Google Scholar]
  3. BASSOE H. H., AARSKOG D., THORSEN T., STOA K. F. CORTISOL PRODUCTION RATE IN PATIENTS WITH ACUTE BACTERIAL INFECTIONS. Acta Med Scand. 1965 Jun;177:701–705. doi: 10.1111/j.0954-6820.1965.tb01880.x. [DOI] [PubMed] [Google Scholar]
  4. BODEY G. P., NIES B. A., MOHBERG N. R., FREIREICH E. J. THE EFFECT OF ADRENAL CORTICOSTEROID THERAPY ON INFECTIONS IN ACUTE LEUKEMIA. Am J Med Sci. 1965 Aug;250:162–167. doi: 10.1097/00000441-196508000-00006. [DOI] [PubMed] [Google Scholar]
  5. CONNOLLY J. E. The use of adrenal cortical compounds in hemorrhagic shock. J Lancet. 1959 Oct;79:460–463. [PubMed] [Google Scholar]
  6. DANIELS W. B. Cause of death in meningococcic infection; analysis of 300 fatal cases. Am J Med. 1950 Apr;8(4):468–473. doi: 10.1016/0002-9343(50)90228-2. [DOI] [PubMed] [Google Scholar]
  7. ECKENHOFF J. E., COOPERMAN L. H. THE CLINICAL APPLICATION OF PHENOXYBENZAMINE IN SHOCK AND VASOCONSTRICTIVE STATES. Surg Gynecol Obstet. 1965 Sep;121:483–490. [PubMed] [Google Scholar]
  8. GELLER P., MERRILL E. R., JAWETZ E. Experimental studies on bacterial contamination of band blood. II. Observations on bacteremia in mice and the influence of antibiotics in preventing death. J Lab Clin Med. 1955 Jun;45(6):943–950. [PubMed] [Google Scholar]
  9. HAKSTIAN R. W., HAMPSON L. G., GURD F. N. Pharmacological agents in experimental hemorrhagic shock. A controlled comparison of treatment with hydralazine, hydrocortisone, and levarterenol (1-norepinephrine). Arch Surg. 1961 Sep;83:335–347. doi: 10.1001/archsurg.1961.01300150009002. [DOI] [PubMed] [Google Scholar]
  10. JAHN J. P., BOLING L., MEAGHER T. R., PETERSON H. H., THOMAS G., FISHER B. M., THILL A. E., LEOVY W. A., BALCH H. E., KINDSELL L. W. The combination of ACTH-cortisone-hydrocortisone with antibiotics in the management of overwhelmingly severe infections: theory and practice based on three years' experience. J Pediatr. 1954 Jun;44(6):640–657. doi: 10.1016/s0022-3476(54)80005-9. [DOI] [PubMed] [Google Scholar]
  11. KASS E. H., FINLAND M. Adrenocortical hormones and the management of infection. Annu Rev Med. 1957;8:1–18. doi: 10.1146/annurev.me.08.020157.000245. [DOI] [PubMed] [Google Scholar]
  12. KASS E. H., FINLAND M. Adrenocortical hormones in infection and immunity. Annu Rev Microbiol. 1953;7:361–388. doi: 10.1146/annurev.mi.07.100153.002045. [DOI] [PubMed] [Google Scholar]
  13. KASS E. H., FINLAND M. Corticosteroids and infections. Adv Intern Med. 1958;9:45–80. [PubMed] [Google Scholar]
  14. KINSELL L. W., JAHN J. P. Combined hormonal-antibiotic therapy in patients with fulminating infections. AMA Arch Intern Med. 1955 Sep;96(3):418–427. doi: 10.1001/archinte.1955.00250140140016. [DOI] [PubMed] [Google Scholar]
  15. KINSELL L. W., JAHN J. P. The use of corticoids in association with antibiotics in the management of unusually severe infections. Ann N Y Acad Sci. 1955 May 27;61(2):397–407. doi: 10.1111/j.1749-6632.1955.tb42490.x. [DOI] [PubMed] [Google Scholar]
  16. LILLEHEI R. C., LONGERBEAM J. K., BLOCH J. H., MANAX W. G. THE NATURE OF IRREVERSIBLE SHOCK: EXPERIMENTAL AND CLINICAL OBSERVATIONS. Ann Surg. 1964 Oct;160:682–710. doi: 10.1097/00000658-196410000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. LILLEHEI R. C., MACLEAN L. D. Physiological approach to successful treatment of endotoxin shock in the experimental animal. AMA Arch Surg. 1959 Mar;78(3):464–471. doi: 10.1001/archsurg.1959.04320030108018. [DOI] [PubMed] [Google Scholar]
  18. MCCRUMB F. R., Jr, LARSON A., MEYER K. F. The chemotherapy of experimental plague in the primate host. J Infect Dis. 1953 May-Jun;92(3):273–287. doi: 10.1093/infdis/92.3.273. [DOI] [PubMed] [Google Scholar]
  19. MELBY J. C., SPINK W. W. Comparative studies on adrenal cortical function and cortisol metabolism in healthy adults and in patients with shock due to infection. J Clin Invest. 1958 Dec;37(12):1791–1798. doi: 10.1172/JCI103772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. NICKERSON M., CARTER S. A. Protection against acute trauma and traumatic shock by vasodilators. Can J Biochem Physiol. 1959 Oct;37:1161–1171. [PubMed] [Google Scholar]
  21. NICKERSON M. Factors of vasoconstriction and vasodilation in shock. J Mich State Med Soc. 1955 Jan;54(1):45–passim. [PubMed] [Google Scholar]
  22. PERRY J. E., CLUFF L. E. MANIFESTATIONS OF FATAL PNEUMOCOCCAL INFECTION IN RABBITS. J Lab Clin Med. 1963 Oct;62:549–558. [PubMed] [Google Scholar]
  23. ROBINSON H. J. Adrenal steroids and resistance to infection. Antibiot Chemother. 1960;7:199–240. doi: 10.1159/000386658. [DOI] [PubMed] [Google Scholar]
  24. SAMBHI M. P., WEIL M. H., UDHOJI V. N. ACUTE PHARMACODYNAMIC EFFECTS OF GLUCOCORTICOIDS; CARDIAC OUTPUT AND RELATED HEMODYNAMIC CHANGES IN NORMAL SUBJECTS AND PATIENTS IN SHOCK. Circulation. 1965 Apr;31:523–530. doi: 10.1161/01.cir.31.4.523. [DOI] [PubMed] [Google Scholar]
  25. UDHOJI V. N., WEIL M. H. HEMODYNAMIC AND METABOLIC STUDIES ON SHOCK ASSOCIATED WITH BACTEREMIA. OBSERVATIONS ON 16 PATIENTS. Ann Intern Med. 1965 May;62:966–978. doi: 10.7326/0003-4819-62-5-966. [DOI] [PubMed] [Google Scholar]
  26. UDHOJI V. N., WEIL M. H., SAMBHI M. P., ROSOFF L. Hemodynamic studies on clinical shock associated with infection. Am J Med. 1963 Apr;34:461–469. doi: 10.1016/0002-9343(63)90068-8. [DOI] [PubMed] [Google Scholar]
  27. VICK J. A. ENDOTOXIN SHOCK IN THE PRIMATE: TREATMENT WITH PHENOXYBENZAMINE. J Clin Invest. 1964 Feb;43:279–284. doi: 10.1172/JCI104912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. WASZ-HOCKERT O. Steroid therapy in acute, life-threatening infections. Acta Paediatr Suppl. 1963;140:79–80. doi: 10.1111/j.1651-2227.1963.tb08712.x. [DOI] [PubMed] [Google Scholar]
  29. WEIL M. H., SHUBIN H., BIDDLE M. SHOCK CAUSED BY GRAM-NEGATIVE MICROORGANISMS. ANALYSIS OF 169 CASES. Ann Intern Med. 1964 Mar;60:384–400. doi: 10.7326/0003-4819-60-3-384. [DOI] [PubMed] [Google Scholar]
  30. WILSON R. F., JABLONSKI D. V., THAL A. P. THE USAGE OF DIBENZYLINE IN CLINICAL SHOCK. Surgery. 1964 Jul;56:172–183. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES